Vycor Medical, Inc.

0.0432

0.0000

Volume:- -

Turnover:- -

Market Cap:1.44M

PE:-3.75

High:0.0432

Open:0.0432

Low:0.0432

Close:0.0432

52wk High:0.2000

52wk Low:0.0311

Shares:33.37M

Float Shares:12.98M

Volume Ratio:0.02

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0115

EPS(LYR):-0.0789

ROE:45.31%

ROA:3.56%

PB:-0.34

PE(LYR):-0.55

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/VYCO"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VYCO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VYCO\",,,,,undefined,":{"symbol":"VYCO","market":"US","secType":"STK","nameCN":"Vycor Medical, Inc.","latestPrice":0.0432,"timestamp":1792785600000,"preClose":0.0432,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":12983419,"shares":33372796,"eps":-0.011515,"marketStatus":"Market Closed","change":0,"latestTime":"10-23 16:00:00 EDT Delay","open":0.0432,"high":0.0432,"low":0.0432,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.011515,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.0432,"volumeRatio":0.01718195341522537},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VYCO\",,,,,undefined,":{"symbol":"VYCO","floatShares":12983419,"roa":"3.56%","roe":"45.31%","lyrEps":-0.078879,"volumeRatio":0.01718195341522537,"shares":33372796,"dividePrice":0,"high":0.0432,"amplitude":0,"preClose":0.0432,"low":0.0432,"week52Low":0.0311,"pbRate":"-0.34","psRate":"0.80","week52High":0.2,"institutionHeld":0,"latestPrice":0.0432,"eps":-0.011515,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.011515,"open":0.0432,"prevYearClose":0.121,"prevWeekClose":0.0672,"prevMonthClose":0.0672,"prevQuarterClose":0.0672,"fiveDayClose":0.0672,"twentyDayClose":0.0672,"sixtyDayClose":0.069},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VYCO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-13","symbol":"VYCO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-08-13","symbol":"VYCO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-15","symbol":"VYCO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-13","symbol":"VYCO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1699851600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-03-27","symbol":"VYCO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1585281600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VYCO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VYCO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VYCO\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659295651","title":"Vycor Medical FY26 Q2 Net Loss Narrows to $2,180; Revenue Falls 16% to $418,264","url":"https://stock-news.laohu8.com/highlight/detail?id=2659295651","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659295651?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:16","pubTimestamp":1786738583,"startTime":"0","endTime":"0","summary":"Vycor Medical FY26 Q2 net loss narrows to $2,180; revenue falls 16% to $418,264Vycor Medical posted revenue of USD 418,264 for the quarter ended June 30, 2026, down 16% year over year.Net loss narrowe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL4cXZ9l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYCO","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635034465","title":"Vycor Medical swings to Q1 FY26 profit of $20,108; revenue rises 5% to $458,540","url":"https://stock-news.laohu8.com/highlight/detail?id=2635034465","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635034465?lang=en_us&edition=fundamental","pubTime":"2026-05-16 02:53","pubTimestamp":1778871238,"startTime":"0","endTime":"0","summary":"Vycor Medical posted net income of USD 20,108 for the three months ended March 31, 2026, swinging from a loss a year earlier.Revenue rose 5% to USD 458,540, led by Vycor Medical segment sales up 5% to USD 440,441.Selling, general and administrative expense fell 10.08% to USD 315,365, while research and development expense was USD 0.Cash climbed to USD 173,634 at March 31, 2026, while working capital deficit widened to USD 4.3 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vycor Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible fo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL7Nbdyx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYCO","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624532151","title":"Vycor Medical FY25 revenue rises 17% to USD 1.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624532151","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624532151?lang=en_us&edition=fundamental","pubTime":"2026-04-01 03:48","pubTimestamp":1774986533,"startTime":"0","endTime":"0","summary":"Vycor Medical posted a net loss of $396,796, or $0.01 per share, for year ended Dec. 31, 2025.Operating income was $33,900, versus an operating loss in 2024.Vycor Medical division revenue climbed 18% to $1,796,070, with most of growth from international markets.NovaVision NeuroEyeCoach study found home-based use delivered meaningful improvements with no significant differences versus clinic-based use.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vycor Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained ther","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLbTbXS4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYCO","BK4198"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VYCO\",params:#limit:6,delay:false,,,undefined,":[]}}